| IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO DE Reuss, Y Mamatjan, D Schrimpf, D Capper, V Hovestadt, A Kratz, ... Acta neuropathologica 129, 867-873, 2015 | 355 | 2015 |
| A clinically applicable integrative molecular classification of meningiomas F Nassiri, J Liu, V Patil, Y Mamatjan, JZ Wang, R Hugh-White, AM Macklin, ... Nature 597 (7874), 119-125, 2021 | 272 | 2021 |
| DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ... Neuro-oncology 21 (7), 901-910, 2019 | 215 | 2019 |
| Adjacent stimulation and measurement patterns considered harmful A Adler, PO Gaggero, Y Maimaitijiang Physiological measurement 32 (7), 731, 2011 | 162 | 2011 |
| Imaging and diagnostic advances for intracranial meningiomas RY Huang, WL Bi, B Griffith, TJ Kaufmann, C la Fougère, NO Schmidt, ... Neuro-oncology 21 (Supplement_1), i44-i61, 2019 | 159 | 2019 |
| Advances in multidisciplinary therapy for meningiomas PK Brastianos, E Galanis, N Butowski, JW Chan, IF Dunn, R Goldbrunner, ... Neuro-oncology 21 (Supplement_1), i18-i31, 2019 | 150 | 2019 |
| The genomic landscape of schwannoma S Agnihotri, S Jalali, MR Wilson, A Danesh, M Li, G Klironomos, ... Nature genetics 48 (11), 1339-1348, 2016 | 142 | 2016 |
| Molecular and translational advances in meningiomas S Suppiah, F Nassiri, WL Bi, IF Dunn, CO Hanemann, CM Horbinski, ... Neuro-oncology 21 (Supplement_1), i4-i17, 2019 | 126 | 2019 |
| Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas S Agnihotri, S Suppiah, PD Tonge, S Jalali, A Danesh, JP Bruce, ... Nature communications 8 (1), 186, 2017 | 95 | 2017 |
| Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life F Nassiri, B Price, A Shehab, K Au, MD Cusimano, MD Jenkinson, ... Neuro-oncology 21 (Supplement_1), i32-i43, 2019 | 87 | 2019 |
| Evaluation of EIT system performance M Yasin, S Böhm, PO Gaggero, A Adler Physiological measurement 32 (7), 851, 2011 | 86 | 2011 |
| CIC protein instability contributes to tumorigenesis in glioblastoma S Bunda, P Heir, J Metcalf, ASC Li, S Agnihotri, S Pusch, M Yasin, M Li, ... Nature communications 10 (1), 661, 2019 | 82 | 2019 |
| The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care S Karimi, JA Zuccato, Y Mamatjan, S Mansouri, S Suppiah, F Nassiri, ... Clinical epigenetics 11, 1-10, 2019 | 73 | 2019 |
| Ketoconazole and posaconazole selectively target HK2-expressing glioblastoma cells S Agnihotri, S Mansouri, K Burrell, M Li, Y Mamatjan, J Liu, R Nejad, ... Clinical Cancer Research 25 (2), 844-855, 2019 | 64 | 2019 |
| Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics Z Wu, Z Abdullaev, D Pratt, HJ Chung, S Skarshaug, V Zgonc, C Perry, ... Neuro-oncology 24 (4), 571-581, 2022 | 51 | 2022 |
| TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy Q Wei, O Singh, C Ekinci, J Gill, M Li, Y Mamatjan, S Karimi, S Bunda, ... Acta neuropathologica communications 9, 1-19, 2021 | 48 | 2021 |
| Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas K Fukuoka, Y Mamatjan, R Tatevossian, M Zapotocky, S Ryall, ... Neuro-oncology 22 (10), 1474-1483, 2020 | 40 | 2020 |
| International Consortium on Meningiomas. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical … F Nassiri, Y Mamatjan, S Suppiah Neuro Oncol 21 (7), 901-910, 2019 | 35 | 2019 |
| Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes S Mirhadi, S Tam, Q Li, N Moghal, NA Pham, J Tong, BJ Golbourn, ... Nature communications 13 (1), 1811, 2022 | 31 | 2022 |
| Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data KA Y. Mamatjan, S. Agnihotri, A. Goldernburg, S. Mansouri, G. Zadeh The Journal of Molecular Diagnostics 19 (6), 881-891, 2017 | 31 | 2017 |
Kenneth AldapeNational Cancer InstituteVerified email at nih.gov
